Human cytomegalovirus vaccine
The disclosure relates to HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
03.01.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The disclosure relates to HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines. |
---|---|
Bibliography: | Application Number: US202117548172 |